
German Chancellor Friedrich Merz and Brazilian President Luiz Inácio Lula da Silva met on the sidelines of G20 talks in South Africa on Saturday, after the German leader sparked outrage with comments on the Brazilian city hosting the COP30 climate talks.
Sources close to the chancellor described Saturday's meeting, which focused on the UN Climate Change Conference in Brazil, tropical rainforest protection and the war in Ukraine, as "very harmonious," though it was unclear whether Merz’s controversial comments were discussed.
Merz had travelled to the Amazon city of Belém for a summit two weeks ago ahead of the annual climate conference. On his return to Berlin, the chancellor said he had asked journalists who accompanied him whether any of them wanted to stay.
"No one raised their hand," Merz said. He argued that the reporters were "happy" to return to Germany, which he described as "one of the most beautiful countries in the world."
The statement triggered anger in Brazil, including from President Lula.
At the time, Lula said Merz should have gone to a bar in Belém, danced and tried out the local cuisine.
LATEST POSTS
- 1
US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships - 2
Creative Style: 10 Architects Reclassifying the Business - 3
The Most Famous Virtual Entertainment Powerhouses of the Year - 4
Taste the World: Five Food sources That Have Dazzled Worldwide Palates - 5
Moon-bound Artemis II astronauts enjoy a relaxed day in space
Ifo: Job cuts in Germany slowing but not enough for a turnaround
EU foreign ministers commemorate Russian massacre in Bucha
True serenity: Investigating Emotional well-being and the Advantages of Contemplation
Email Promoting Instruments for Compelling Efforts
In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
How the Iran war may affect your money and bills
Cheetah, Hammerhead Shark, and 38 Other Animals in Danger of Extinction Receive New International Protections from U.N.
vote in favor of Your #1 kind of climate
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug













